Real-world evidence of first-line Osimertinib effectiveness in Bulgarian patients: a retrospective analysis

First published 29/07/2025

Last updated 29/07/2025

EU PAS number:

EUPAS1000000686

Study

Finalised

Download as PDF

Documents

Study protocol

Study results

Study report

Study report

Real-world evidence of first-line osimertinib effectiveness in Bulgarian patients a retrospective analysis.pdf

English (1.57 MB - PDF) View document

Other information

Publications

Study publications

Real-world evidence of first-line osimertinib effectiveness in Bulgarian patien…